Background The prognosis of metabolic dysfunction-associated steatotic liver disease
(MASLD) is strongly associated with liver fibrosis. We aimed to investigate whether liver …

Abstract Background & Aims Patients with advanced fibrosis related to nonalcoholic fatty
liver disease (NAFLD) are at risk of developing hepatic and extrahepatic complications. We …

Background Liver stiffness measurement (LSM) has been used to measure fibrosis in
patients with various types of chronic liver diseases. However, its usefulness as a screening …

Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) has recently
been proposed as a replacement term for NAFLD. Aims To assess the effects of this new …

Background Early and accurate non‐invasive diagnosis of liver fibrosis is important for
reducing the burden of cirrhosis and related complications. Aim This cross‐sectional study …

Background Systemic sclerosis (SSc) is a multisystem disease associated with significant
morbidity and increased mortality. The prevalence of different gastrointestinal (GI) …

Systemic sclerosis (SSc) is a complex autoimmune disease that may lead to skin and
internal organ fibrosis. Based on skin involvement, two subsets of the disease are …

Background Up to 50% of patients with common variable immunodeficiency (CVID) present
persistently increased serum levels of liver enzymes and/or mild hepatomegaly. Ultrasound …

AIM: To investigate the prevalence of significant liver fibrosis assessed using transient
elastography (TE) and its predictors in asymptomatic general population. METHODS: A total …

Background & Aims: Many patients with nonalcoholic fatty liver disease (NAFLD) have a
benign clinical course, but a subgroup of patients progress to advanced fibrosis and …